Literature DB >> 3334972

An experience with an implanted port system in 66 children with cancer.

D L Becton1, M Kletzel, E S Golladay, G Hathaway, D H Berry.   

Abstract

Totally implanted port catheter systems have a lower incidence of infection and are more easily used in home care that external catheters in adult cancer patients. Experience with this method in children has been limited. During the past 2 years, we have implanted 71 ports in 66 children with cancer. Our experience demonstrates an infection rate (0.15 episodes of bacteremia per 100 patient days) slightly lower than that reported for children with Broviac or Hickman catheters, but not as low as that seen in adults with implanted systems. Patients and families have been extremely satisfied with the devices. Our experience supports further use of implanted systems in children with cancer.

Entities:  

Mesh：

Year:  1988        PMID： 3334972     DOI： 10.1002/1097-0142(19880115)61:2<376::aid-cncr2820610229>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  7 in total

1.  Vancomycin and ceftazidime bioactivities persist for at least 2 weeks in the lumen in ports: simplifying treatment of port-associated bloodstream infections by using the antibiotic lock technique.

Authors:  Y Haimi-Cohen; N Husain; J Meenan; G Karayalcin; M Lehrer; L G Rubin
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  Central venous catheter tip position and malfunction in a paediatric oncology unit.

Authors:  H Lucas; S P Attard-Montalto; V Saha; A Bristow; J E Kingston; O B Eden
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

Review 3.  Antimicrobial therapy in palliative care: an overview.

Authors:  Filipa Macedo; Catarina Nunes; Katia Ladeira; Filipa Pinho; Nadine Saraiva; Nuno Bonito; Luísa Pinto; Francisco Gonçalves
Journal:  Support Care Cancer       Date:  2018-02-12       Impact factor: 3.603

4.  Morbidity using subcutaneous ports and efficacy of vancomycin flushing in cancer.

Authors:  H Rubie; M Juricic; S Claeyssens; A Krimou; J Lemozy; P Izard; J Guitard; M Ane; M F Prere; F Fedacou
Journal:  Arch Dis Child       Date:  1995-04       Impact factor: 3.791

5.  It appears to be safe to start chemotherapy on the day of implantation through subcutaneous venous port catheters in inpatient setting.

Authors:  Nuriye Yildirim Ozdemir; Hüseyin Abali; Berna Oksüzoğlu; Burçin Budakoğlu; Ilkay Akmangit; Nurullah Zengin
Journal:  Support Care Cancer       Date:  2008-09-02       Impact factor: 3.603

6.  Implantable versus cuffed external central venous catheters for the management of children and adolescents with acute lymphoblastic leukaemia.

Authors:  Alan D White; Diaa Othman; Michael J Dawrant; Soroush Sohrabi; Alastair L Young; Roly Squire
Journal:  Pediatr Surg Int       Date:  2012-11-23       Impact factor: 1.827

7.  Transluminal removal of a fractured and embolized indwelling central venous catheter in the pulmonary artery.

Authors:  O Kil Kim; Su Hong Kim; Jong Bin Kim; Woo Seong Jeon; Sung Hwan Jo; Jee Hyun Lee; Ji Ho Ko
Journal:  Korean J Intern Med       Date:  2006-09       Impact factor: 2.884
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.